Article Excerpt: IBM’s cognitive learning platform will be integrated into Boston Children’s Hospital to help researchers at the Manton Center for Orphan Disease Research in their study of steroid-resistant neophrotic syndrome (SRNS), a rare genetic form of kidney disease. Watson will first scour all available literature and related information on SRNS, then be used to process genomic data from patients at Boston Children’s to help researchers identify and develop treatment options for the disease.The partnership was announced this week at Boston Children’s Hospital’s Global Pediatric Innovation Summit in Boston and at the HIMSS Connected Health Conference outside Washington D.C., where IBM Chief Science Officer and Vice President of Innovations Shahram Ebadollahi was giving a keynote.
Full Article: http://tinyurl.com/p8s325z
Article Source: mHealth News